Login / Signup

Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.

Kellie MorlandChristian GergesJean ElwingScott H VisovattiJason WeatheraldKari R GillmeyerAdriano R TonelliStephen C MathaiAthénaïs BouclyPaul G WilliamsSivadasanpillai HarikrishnanEvan P MintyLukas HobohmArun JoseRoberto BadagliaccaEdmund M T LauZhi-Cheng JingRebecca R VanderpoolCharles FauvelJose Leonidas AlvesGeoff StrangeTomas PulidoJunyan QianMengtao LiValentina MercurioJason G E ZeltVictor M MolesMeghan M CirulisSylvia M NikkhoRaymond L BenzaC Gregory Elliott
Published in: Pulmonary circulation (2023)
This manuscript on real-world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real-World Evidence Working Group. We aim to strengthen the research community's understanding of RWE in PH to facilitate clinical research advances and ultimately improve patient care. Herein, we review real-world data (RWD) sources, discuss challenges and opportunities when using RWD sources to study PH populations, and identify resources needed to support the generation of meaningful RWE for the global PH community.
Keyphrases
  • pulmonary hypertension
  • pulmonary artery
  • healthcare
  • pulmonary arterial hypertension
  • mental health
  • machine learning
  • electronic health record
  • big data
  • deep learning